Silicon Valley Capital Partners »

Acelrx Pharmaceuticals shares owned by Silicon Valley Capital Partners

Quarter-by-quarter ownership of Acelrx Pharmaceuticals (TLPH) shares owned by Silicon Valley Capital Partners from 13F filings

Historical chart of Silicon Valley Capital Partners investment in Acelrx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acelrx Pharmaceuticals held by Silicon Valley Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelrx Pharmaceuticals by Silicon Valley Capital Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $116 137 0.85
2024-06-30 $121 137 0.89
2024-03-31 $141 137 1.03
2023-12-31 $100 137 0.74
2023-09-30 $78 137 0.58
2023-06-30 $152 137 1.11
2023-03-31 $89 137 0.66
2022-12-31 $310 137 2.26

More positions owned by Silicon Valley Capital Partners

Spdr S&p 500 Etf Trust Etf (SPY)
Invesco Qqq Trust Series I Etf (QQQ)
Apple Stock (AAPL)
Invesco S&p 500 Garp Etf Etf (SPGP)
Vanguard Information Technology Etf Etf (VGT)
Microsoft Corp Stock (MSFT)
Nvidia Corporation Stock (NVDA)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Ishares S&p 500 Growth Etf Etf (IVW)
Amazon Stock (AMZN)
Vanguard Growth Etf Etf (VUG)
Tr Activebeta Us Large Cap Equity Etf Etf (GSLC)
Starbucks Corp Stock (SBUX)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Meta Platforms Inc Cl A Stock (META)

View all positions for Silicon Valley Capital Partners

Top funds holding Acelrx Pharmaceuticals

Nantahala Capital Management
Rosalind Advisors
Rock Springs Capital Management
MAI Wealth Advisors
Vanguard Group
Royal Bank of Canada
Geode Capital Management
Values First Advisors
BlackRock
Susquehanna International
Turtle Creek Wealth Advisors
Two Sigma Securities
Citadel Advisors
State Street Corporation
Tower Research Capital

View all funds holding Acelrx Pharmaceuticals